Please contact our sales representative to learn more information about this reagents.
Background
Lorvotuzumab mertansine (IMGN901) is an antibody-drug conjugate. It comprises the CD56-binding antibody, lorvotuzumab (huN901), with a maytansinoid cell-killing3 KB (178 words) - 17:21, 7 March 2021.